Detalhe da pesquisa
1.
Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma.
Eur J Nucl Med Mol Imaging
; 51(4): 1085-1096, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37982850
2.
Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer.
Eur J Nucl Med Mol Imaging
; 51(6): 1763-1772, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38200396
3.
PSMA PET/CT: joint EANM procedure guideline/SNMMI procedure standard for prostate cancer imaging 2.0.
Eur J Nucl Med Mol Imaging
; 50(5): 1466-1486, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604326
4.
Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 50(9): 2830-2845, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37246997
5.
Preclinical Evaluation of a Companion Diagnostic Radiopharmaceutical, [18F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft Mouse Model.
Mol Pharm
; 20(2): 1050-1060, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583623
6.
Equilibrium Thermodynamics of Macropa Complexes with Selected Metal Isotopes of Radiopharmaceutical Interest.
Inorg Chem
; 62(50): 20699-20709, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702665
7.
Bispidine Chelators for Radiopharmaceutical Applications with Lanthanide, Actinide, and Main Group Metal Ions.
Inorg Chem
; 62(50): 20754-20768, 2023 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707798
8.
Improved protocol for the radiosynthesis of [18 F]FTC-146: A potent and selective sigma-1 receptor radioligand.
J Labelled Comp Radiopharm
; 66(3): 116-125, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807307
9.
Toward Personalized Medicine: One Chelator for Imaging and Therapy with Lutetium-177 and Actinium-225.
J Am Chem Soc
; 144(47): 21555-21567, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382991
10.
Investigation of Tumor Cells and Receptor-Ligand Simulation Models for the Development of PET Imaging Probes Targeting PSMA and GRPR and a Possible Crosstalk between the Two Receptors.
Mol Pharm
; 19(7): 2231-2247, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35467350
11.
Automated radiosynthesis of the adenosine A2A receptor-targeting radiotracer [18 F]FLUDA.
J Labelled Comp Radiopharm
; 65(6): 162-166, 2022 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35288969
12.
Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice.
Int J Mol Sci
; 23(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35162950
13.
Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours.
Molecules
; 27(12)2022 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35744895
14.
Synthesis and application of a thiol-reactive HBED-type chelator for development of easy-to-produce Ga-radiopharmaceutical kits and imaging probes.
Org Biomol Chem
; 19(8): 1722-1726, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33527964
15.
18F-Labeled Small-Molecule and Low-Molecular-Weight PET Tracers for the Noninvasive Detection of Cancer.
Recent Results Cancer Res
; 216: 283-318, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32594390
16.
Synthesis, characterization and evaluation of 68Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor.
Bioorg Chem
; 100: 103855, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32428743
17.
Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?
Eur J Nucl Med Mol Imaging
; 46(5): 1081-1091, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30603987
18.
Correction to: Radiosynthesis and biological evaluation of [18F]AG-120 for PET imaging of the mutant isocitrate dehydrogenase 1 in glioma.
Eur J Nucl Med Mol Imaging
; 51(4): 1199-1200, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252162
19.
EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT).
Eur J Nucl Med Mol Imaging
; 46(12): 2536-2544, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440799
20.
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay.
Mutagenesis
; 34(3): 239-244, 2019 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31107537